Future Directions in the Treatment of Mantle Cell Lymphoma

Opinion
Video

Kami Maddocks, MD, and Alexey Danilov, MD, PhD, close their discussion with a look at the future treatment landscape of mantle cell lymphoma.

Related Videos
A panel of 3 experts on breast cancer
A panel of 3 experts on breast cancer
Video 2 - "Navigating Glioblastoma Imaging: The Patient Journey from Diagnosis to Treatment "
Video 1 - "Neuroimaging of Glioblastoma"
Video 11 - "Pioneering Breakthroughs in HCC Treatment"
A panel of 3 experts on breast cancer
A panel of 3 experts on breast cancer
Jean L. Koff, MD, MS
Video 10 -"Real-World Evidence on Second-Line Therapy Selection and Outcomes"
Video 9 - "Additional Second-Line Treatments for HCC"
Related Content
MCL | Image Credit: ©freshidea - stock.adobe.com

Adding Ibrutinib to Chemoimmunotherapy Induction Improves FFS in Younger MCL

May 20th 2024
Article
Lori A. Leslie, MD

FDA Approval Insights: Pirtobrutinib in MCL

February 27th 2023
Podcast
Jean L. Koff, MD, MS, Winship Cancer Institute

Efficacy and Safety of Pirtobrutinib Continue to Reshape MCL Treatment Paradigm

May 13th 2024
Article
Joshua Brody, MD

Brody Previews ASH 2022 Data With Pirtobrutinib, CAR T-cell Therapy, and Glofitamab in MCL

December 8th 2022
Podcast
MCL | Image Credit: ©freshidea - stock.adobe.com

Zanubrutinib Associated With Longer Treatment Persistence, Duration, and TTD in Real-World MCL

April 17th 2024
Article
stock.adobe.com

B-Cell Receptor Signaling Activity Portends Inferior Outcomes in MCL

April 17th 2024
Article